Medikabazaar appoints Jitesh Mathur as Sr. Vice President, Business Development

IMT News Desk
IMT News Desk
· 3 min read
Jitesh Mathur – Vice President at MedikaBazaar

National, September 24th 2019: Underlying its aim to make high-quality healthcare solutions accessible and affordable for providers and end-users pan-India, Medikabazaar India’s largest online B2B platform for medical supplies, today announced the appointment of Jitesh Mathur as Senior Vice President – Business Development. In his role at the company, Jitesh will be responsible for unlocking the value procurement potential across various chains of hospitals, new product business assistance and key manufacturer alliances. In addition to this, he will oversee the strengthening of the MedikaRecyle refurbished business and equipment services team.

Having been in leadership roles across sales, business management, marketing, and product management, Jitesh brings with him over two decades of diverse experience and specializes in Technology, Healthcare and IT. The organizations he has worked at include Philips Health Care, Hewlett Packard, Agilent Technologies, Wipro Biomed and Toshniwal Brothers Limited. Prior to joining Medikabazaar, Jitesh’s most recent role was that of Head – Global Marketing and Sales at SS Innovations.

Speaking on the appointment, Vivek Tiwari, Founder and CEO, Medikabazaar said, “We are happy to have Mr. Jitesh Mathur come on board as SVP, Business Development. His extensive experience will help us bolster our growth plans in terms of strengthening our partner base as well as optimizing procurement for a larger number of healthcare providers in order to boost accessibility to high-quality healthcare for end-users.”

Commenting on the same, Jitesh Mathur, SVP, Business Development, Medikabazaar, said, “Medikabazaar is pioneering compelling value propositions in the procurement processes for the Indian healthcare industry. Already a partner of choice to thousands of customers, growing and scaling up at an unbelievable pace, it is addressing one of the key issues faced by healthcare providers across our country which is availability, reliability and costs of medical equipment consumables and supplies. It’s a privilege and a great opportunity for me to join this journey and contribute to the goals of achieving efficiency and large scale procurement aggregation to expand the access and reach of healthcare across India and beyond.”

Since its inception in 2015, Medikabazaar has emerged as a segment leader in the healthcare space. It aims to optimize the procurement costs of medical facilities and equipment for healthcare providers across the country by eliminating the need for intermediaries. Medikabazaar is currently focusing on expanding its team, diversifying into new product categories and strengthening its technological infrastructure. The hiring of Jitesh Mathur is aimed at reimagining the company’s business model across divisions to streamline its offerings, build manufacturer alliances and increase its reach to providers and end users alike.

Read Next

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management
Corporate
January 27, 2026

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management

Company to launch product after the expiry of semaglutide patent in India Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight management in adults as an adjunct to […]
Article by: IMT News Desk
Lupin receives highest ESG rating from CDP for climate change and water security
Corporate
January 27, 2026

Lupin receives highest ESG rating from CDP for climate change and water security

The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency at the highest level Lupin has received the highest ‘A’ leadership rating from Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency […]
Article by: IMT News Desk
AstraZeneca Pharma India receives CDSCO approval for breast cancer drug
Corporate
December 19, 2025

AstraZeneca Pharma India receives CDSCO approval for breast cancer drug

Dato-DXd is a specifically engineered antibody drug conjugate that targets TROP2, a protein frequently overexpressed in breast cancer AstraZeneca Pharma India announced that the Central Drugs Standard Control Organisation (CDSCO) has granted regulatory approval to import, sell, and distribute Datopotamab Deruxtecan (Dato-DXd) in India. The approval reflects AstraZeneca’s focus on bringing to life-changing medicines at […]
Article by: IMT News Desk
Novo Nordisk launches Ozempic in India
Corporate
December 12, 2025

Novo Nordisk launches Ozempic in India

Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living with uncontrolled type 2 diabetes mellitus Novo Nordisk announced the launch of Ozempic (injectable semaglutide) in India. Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living […]
Article by: IMT News Desk